AI assistant
Marel — Director's Dealing 2020
Oct 27, 2020
2191_rns_2020-10-27_5df98c1f-e1af-4b58-bebe-4a70e75c9c83.pdf
Director's Dealing
Open in viewerOpens in your device viewer
SEDLABAT 1. SLANDS
FJÁRMÁLA EFTIRLIT
Viðskipti fruminnherja/
Transaction of primary insider
Vinsamlegast tilkynnist til [email protected]/
Please send the form to [email protected]
Auðkenni útgefanda/Trade ticker: MAREL
Nafn útgefanda/Issuer: Marel hf.
Dagsetning tilkynningar/Date of announcement: 27.10.2020
Nafn fruminnherja/Name primary insider: Árni Oddur Þórðarson
Tengsl fruminnherja við útgefanda/Insider's relation with the issuer: Forstjóri / CEO
Dagsetning viðskipta/Date of transaction: 27.10.2020
Tímasetning viðskipta/Time of transaction: 0
Tegund fjármálagernings/Type of financial instrument: Hlutabréf / Equities
Kaup eða sala/Buy or Sell: Kaup
Fjöldi hluta/Number of shares: 278.009
Verð pr. Hlut/Price per share: EUR 2,349
Fjöldi hluta í eigu fruminnherja eftir viðskipti/Primary insider's holdings after the transaction: 342.643
Fjöldi hluta sem fruminnherji á kauprétt að/Primary insider's option holdings after the transaction: 1.952.000
Fjöldi hluta fjárhagslega tengdra aðila eftir viðskipti/Related parties' holdings after the transaction: 67.235
Dagsetning lokauppgjørs/Date of settlement: 0
¹ Fruminnherji á jafnframt 17,9% hlut í Eyri Invest hf. sem er stærsti hluthafi Marel hf. / Primary insider holds 17.9% of total share capital of Eyrir Invest hf., which is Marel's largest shareholder.
FJÁRMÁLA EFTIRLIT
Athugasemdir/Comments:
Viðskiptin eru til að mæta skilyrðum um framkvæmd kaupréttarsamninga. Kaupréttirnir voru veittir árin 2016 og 2017 á grundvelli starfskjarastefnu félagsins eins og hún var samþykkt af aðalfundi á hverjum tíma. Móttekin bréf nema mismun á vegnu meðalkaupverði kaupréttanna sem var 2,349 evrur á hlut og dagslokagengi á Euronext Amsterdam þann 26.10.2020, hvort tveggja margfaldað með fjölda nýttra kauprétta sem voru 888.000, að frádregnum sköttum.
Transaction to fulfill obligations of stock option agreements. The stock options were granted in the years 2016 and 2017 in accordance with the Company's Remuneration Policy as approved at the Company's respective AGMs. Received shares equal the difference of the weighted average exercise price of the stock options (EUR 2.349 per share) and closing price on Euronext Amsterdam on 26 October 2020, both numbers multiplied with the number of exercised stock options which were 888,000, less taxes.
2